These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19604247)

  • 1. Up-regulation of integrin beta3 in radioresistant pancreatic cancer impairs adenovirus-mediated gene therapy.
    Egami T; Ohuchida K; Yasui T; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
    Cancer Sci; 2009 Oct; 100(10):1902-7. PubMed ID: 19604247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.
    Egami T; Ohuchida K; Miyoshi K; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
    Cancer Sci; 2009 Apr; 100(4):722-9. PubMed ID: 19302285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells.
    Onimaru M; Ohuchida K; Egami T; Mizumoto K; Nagai E; Cui L; Toma H; Matsumoto K; Hashizume M; Tanaka M
    Cancer Gene Ther; 2010 Aug; 17(8):541-9. PubMed ID: 20395979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells.
    Onimaru M; Ohuchida K; Mizumoto K; Nagai E; Cui L; Toma H; Takayama K; Matsumoto K; Hashizume M; Tanaka M
    Cancer Sci; 2010 Mar; 101(3):735-42. PubMed ID: 20059477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells.
    Yasui T; Ohuchida K; Zhao M; Cui L; Onimaru M; Egami T; Fujita H; Ohtsuka T; Mizumoto K; Matsumoto K; Tanaka M
    Anticancer Res; 2011 Apr; 31(4):1279-87. PubMed ID: 21508376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based protein delivery system for the inhibition of the growth of pancreatic cancer: NK4 gene-transduced oral mucosal epithelial cell sheet.
    Manabe T; Mizumoto K; Nagai E; Matsumoto K; Nakamura T; Nukiwa T; Tanaka M; Matsuda T
    Clin Cancer Res; 2003 Aug; 9(8):3158-66. PubMed ID: 12912968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
    Murakami M; Nagai E; Mizumoto K; Saimura M; Ohuchida K; Inadome N; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Int J Cancer; 2005 Oct; 117(1):160-5. PubMed ID: 15880501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer.
    Maehara N; Nagai E; Mizumoto K; Sato N; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Clin Exp Metastasis; 2002; 19(5):417-26. PubMed ID: 12198770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
    Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
    Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
    Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
    Jie JZ; Wang JW; Qu JG; Hung T
    World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
    Deng XB; Xiao L; Wu Y; Jin F; Mossman B; Testa JR; Xiao GH
    Int J Cancer; 2015 Jul; 137(2):481-90. PubMed ID: 25501304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Haraguchi N; Inoue H; Murayama S; Mori M
    Int J Oncol; 2006 Mar; 28(3):705-13. PubMed ID: 16465376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model.
    Tanaka T; Shimura H; Sasaki T; Narumi K; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Ikeda S
    Cancer Gene Ther; 2004 Jun; 11(6):431-40. PubMed ID: 15118756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
    J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    J Exp Clin Cancer Res; 2008 Aug; 27(1):30. PubMed ID: 18717994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
    Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B
    Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.